 | • レポートコード：MRC2Q12-19407 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、セレキシパグのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 セレキシパグのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 セレキシパグの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 セレキシパグのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのセレキシパグの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のセレキシパグの売上および2028年までの予測に焦点を当てています。 セレキシパグのグローバル主要企業には、Haosoh Pharma、Johnson and Johnson、MSN Lab、Zydus Worldwide DMCC、Nippon Shinyakuなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 セレキシパグ市場は、タイプとアプリケーションによって区分されます。世界のセレキシパグ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 0.2Mg、0.4Mg、0.8Mg、その他 【アプリケーション別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - セレキシパグ製品概要 - タイプ別市場（0.2Mg、0.4Mg、0.8Mg、その他） - アプリケーション別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のセレキシパグ販売量予測2017-2028 - 世界のセレキシパグ売上予測2017-2028 - セレキシパグの地域別販売量 - セレキシパグの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別セレキシパグ販売量 - 主要メーカー別セレキシパグ売上 - 主要メーカー別セレキシパグ価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（0.2Mg、0.4Mg、0.8Mg、その他） - セレキシパグのタイプ別販売量 - セレキシパグのタイプ別売上 - セレキシパグのタイプ別価格 ・アプリケーション別市場規模（病院、クリニック、その他） - セレキシパグのアプリケーション別販売量 - セレキシパグのアプリケーション別売上 - セレキシパグのアプリケーション別価格 ・北米市場 - 北米のセレキシパグ市場規模（タイプ別、アプリケーション別） - 主要国別のセレキシパグ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのセレキシパグ市場規模（タイプ別、アプリケーション別） - 主要国別のセレキシパグ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のセレキシパグ市場規模（タイプ別、アプリケーション別） - 主要国別のセレキシパグ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のセレキシパグ市場規模（タイプ別、アプリケーション別） - 主要国別のセレキシパグ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのセレキシパグ市場規模（タイプ別、アプリケーション別） - 主要国別のセレキシパグ市場規模（トルコ、サウジアラビア） ・企業情報 Haosoh Pharma、Johnson and Johnson、MSN Lab、Zydus Worldwide DMCC、Nippon Shinyaku ・産業チェーン及び販売チャネル分析 - セレキシパグの産業チェーン分析 - セレキシパグの原材料 - セレキシパグの生産プロセス - セレキシパグの販売及びマーケティング - セレキシパグの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - セレキシパグの産業動向 - セレキシパグのマーケットドライバー - セレキシパグの課題 - セレキシパグの阻害要因 ・主な調査結果 |
Drugs used to treat pulmonary hypertension
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Selexipag is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Selexipag is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Selexipag is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Selexipag include Haosoh Pharma, Johnson and Johnson, MSN Lab, Zydus Worldwide DMCC and Nippon Shinyaku, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Selexipag manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Selexipag market. Further, it explains the major drivers and regional dynamics of the global Selexipag market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Haosoh Pharma
Johnson and Johnson
MSN Lab
Zydus Worldwide DMCC
Nippon Shinyaku
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by dosage strength and by application segments based on sales, price, and value for the period 2017-2028.
Selexipag Segment by Dosage Strength
0.2Mg
0.4Mg
0.8Mg
Other
Selexipag Segment by Application
Hospital
Clinic
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Selexipag market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Selexipag, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Selexipag, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Selexipag, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Selexipag sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Selexipag market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Selexipag sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Haosoh Pharma, Johnson and Johnson, MSN Lab, Zydus Worldwide DMCC and Nippon Shinyaku, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Selexipag in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Selexipag manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Selexipag sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Selexipag Product Introduction
1.2 Market by Dosage Strength
1.2.1 Global Selexipag Market Size Growth Rate by Dosage Strength, 2017 VS 2021 VS 2028
1.2.2 0.2Mg
1.2.3 0.4Mg
1.2.4 0.8Mg
1.2.5 Other
1.3 Market by Application
1.3.1 Global Selexipag Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Selexipag Sales Estimates and Forecasts 2017-2028
2.2 Global Selexipag Revenue Estimates and Forecasts 2017-2028
2.3 Global Selexipag Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Selexipag Sales by Region
2.4.1 Global Selexipag Sales by Region (2017-2022)
2.4.2 Global Sales Selexipag by Region (2023-2028)
2.5 Global Selexipag Revenue by Region
2.5.1 Global Selexipag Revenue by Region (2017-2022)
2.5.2 Global Selexipag Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Selexipag Sales by Manufacturers
3.1.1 Global Top Selexipag Manufacturers by Sales (2017-2022)
3.1.2 Global Selexipag Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Selexipag in 2021
3.2 Global Selexipag Revenue by Manufacturers
3.2.1 Global Selexipag Revenue by Manufacturers (2017-2022)
3.2.2 Global Selexipag Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Selexipag Revenue in 2021
3.3 Global Selexipag Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Selexipag Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Selexipag Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Dosage Strength
4.1 Global Selexipag Sales by Dosage Strength
4.1.1 Global Selexipag Historical Sales by Dosage Strength (2017-2022)
4.1.2 Global Selexipag Forecasted Sales by Dosage Strength (2023-2028)
4.1.3 Global Selexipag Sales Market Share by Dosage Strength (2017-2028)
4.2 Global Selexipag Revenue by Dosage Strength
4.2.1 Global Selexipag Historical Revenue by Dosage Strength (2017-2022)
4.2.2 Global Selexipag Forecasted Revenue by Dosage Strength (2023-2028)
4.2.3 Global Selexipag Revenue Market Share by Dosage Strength (2017-2028)
4.3 Global Selexipag Price by Dosage Strength
4.3.1 Global Selexipag Price by Dosage Strength (2017-2022)
4.3.2 Global Selexipag Price Forecast by Dosage Strength (2023-2028)
5 Market Size by Application
5.1 Global Selexipag Sales by Application
5.1.1 Global Selexipag Historical Sales by Application (2017-2022)
5.1.2 Global Selexipag Forecasted Sales by Application (2023-2028)
5.1.3 Global Selexipag Sales Market Share by Application (2017-2028)
5.2 Global Selexipag Revenue by Application
5.2.1 Global Selexipag Historical Revenue by Application (2017-2022)
5.2.2 Global Selexipag Forecasted Revenue by Application (2023-2028)
5.2.3 Global Selexipag Revenue Market Share by Application (2017-2028)
5.3 Global Selexipag Price by Application
5.3.1 Global Selexipag Price by Application (2017-2022)
5.3.2 Global Selexipag Price Forecast by Application (2023-2028)
6 North America
6.1 North America Selexipag Market Size by Dosage Strength
6.1.1 North America Selexipag Sales by Dosage Strength (2017-2028)
6.1.2 North America Selexipag Revenue by Dosage Strength (2017-2028)
6.2 North America Selexipag Market Size by Application
6.2.1 North America Selexipag Sales by Application (2017-2028)
6.2.2 North America Selexipag Revenue by Application (2017-2028)
6.3 North America Selexipag Market Size by Country
6.3.1 North America Selexipag Sales by Country (2017-2028)
6.3.2 North America Selexipag Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Selexipag Market Size by Dosage Strength
7.1.1 Europe Selexipag Sales by Dosage Strength (2017-2028)
7.1.2 Europe Selexipag Revenue by Dosage Strength (2017-2028)
7.2 Europe Selexipag Market Size by Application
7.2.1 Europe Selexipag Sales by Application (2017-2028)
7.2.2 Europe Selexipag Revenue by Application (2017-2028)
7.3 Europe Selexipag Market Size by Country
7.3.1 Europe Selexipag Sales by Country (2017-2028)
7.3.2 Europe Selexipag Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Selexipag Market Size by Dosage Strength
8.1.1 Asia Pacific Selexipag Sales by Dosage Strength (2017-2028)
8.1.2 Asia Pacific Selexipag Revenue by Dosage Strength (2017-2028)
8.2 Asia Pacific Selexipag Market Size by Application
8.2.1 Asia Pacific Selexipag Sales by Application (2017-2028)
8.2.2 Asia Pacific Selexipag Revenue by Application (2017-2028)
8.3 Asia Pacific Selexipag Market Size by Region
8.3.1 Asia Pacific Selexipag Sales by Region (2017-2028)
8.3.2 Asia Pacific Selexipag Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Selexipag Market Size by Dosage Strength
9.1.1 Latin America Selexipag Sales by Dosage Strength (2017-2028)
9.1.2 Latin America Selexipag Revenue by Dosage Strength (2017-2028)
9.2 Latin America Selexipag Market Size by Application
9.2.1 Latin America Selexipag Sales by Application (2017-2028)
9.2.2 Latin America Selexipag Revenue by Application (2017-2028)
9.3 Latin America Selexipag Market Size by Country
9.3.1 Latin America Selexipag Sales by Country (2017-2028)
9.3.2 Latin America Selexipag Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Selexipag Market Size by Dosage Strength
10.1.1 Middle East and Africa Selexipag Sales by Dosage Strength (2017-2028)
10.1.2 Middle East and Africa Selexipag Revenue by Dosage Strength (2017-2028)
10.2 Middle East and Africa Selexipag Market Size by Application
10.2.1 Middle East and Africa Selexipag Sales by Application (2017-2028)
10.2.2 Middle East and Africa Selexipag Revenue by Application (2017-2028)
10.3 Middle East and Africa Selexipag Market Size by Country
10.3.1 Middle East and Africa Selexipag Sales by Country (2017-2028)
10.3.2 Middle East and Africa Selexipag Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Haosoh Pharma
11.1.1 Haosoh Pharma Corporation Information
11.1.2 Haosoh Pharma Overview
11.1.3 Haosoh Pharma Selexipag Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Haosoh Pharma Selexipag Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Haosoh Pharma Recent Developments
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Corporation Information
11.2.2 Johnson and Johnson Overview
11.2.3 Johnson and Johnson Selexipag Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson and Johnson Selexipag Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson and Johnson Recent Developments
11.3 MSN Lab
11.3.1 MSN Lab Corporation Information
11.3.2 MSN Lab Overview
11.3.3 MSN Lab Selexipag Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 MSN Lab Selexipag Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MSN Lab Recent Developments
11.4 Zydus Worldwide DMCC
11.4.1 Zydus Worldwide DMCC Corporation Information
11.4.2 Zydus Worldwide DMCC Overview
11.4.3 Zydus Worldwide DMCC Selexipag Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Zydus Worldwide DMCC Selexipag Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zydus Worldwide DMCC Recent Developments
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Corporation Information
11.5.2 Nippon Shinyaku Overview
11.5.3 Nippon Shinyaku Selexipag Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nippon Shinyaku Selexipag Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nippon Shinyaku Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Selexipag Industry Chain Analysis
12.2 Selexipag Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Selexipag Production Mode & Process
12.4 Selexipag Sales and Marketing
12.4.1 Selexipag Sales Channels
12.4.2 Selexipag Distributors
12.5 Selexipag Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Selexipag Industry Trends
13.2 Selexipag Market Drivers
13.3 Selexipag Market Challenges
13.4 Selexipag Market Restraints
14 Key Findings in The Global Selexipag Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer